跳至主要内容
临床试验/NCT06818981
NCT06818981尚未招募2 期

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Post-Operative Steroids After Sleep Surgery

Medical University of South Carolina2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年7月1日最近更新:
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
120
试验地点
2
主要终点
Pain control

研究概览

简要总结

The primary objective of this randomized, placebo-controlled, double-blind study will be to determine if postoperative steroids significantly improve subjects' pain compared to a placebo after undergoing sleep surgery. The secondary objective is to determine if this same course of steroids improves how quickly subjects can tolerate a regular diet after surgery. Further, another secondary objective is to see if this will decrease a patient's postoperative narcotic usage. Investigators also will assess sleepiness, nasal breathing, and eustachian tube dysfunction (ETD) after the procedure using the validated measures Preoperative Epworth Sleepiness Scale (ESS), Nasal Obstruction Symptom Evaluation Survey (NOSE), and Eustachian Tube Dysfunction Questionnaire (ETDQ-7) with an objective to see if these improve more or quicker in patients who receive postoperative steroids. Investigators hypothesize that postoperative steroids will significantly decrease a patient's pain quicker in their recovery, allow them to tolerate more oral intake early in their recovery, allow them to tolerate a regular diet earlier in their recovery, and reduce their postoperative narcotic usage. Investigators hypothesize that postoperative steroids will also improve patients' ESS, NOSE, and ETD scores postoperatively, but Investigators do not believe postoperative steroids will affect the oropharyngeal bleeding rate of patients. This study will provide pilot data to determine if postoperative steroids and what dosage should be part of a standardized postoperative regimen in patients undergoing sleep surgery.

详细描述

Obstructive sleep apnea (OSA) is a multifactorial disease that negatively affects almost every system in the body. While continuous positive airway pressure (CPAP) can be used as an effective treatment, there are many reasons that patients cannot tolerate CPAP, including claustrophobia, rhinitis sicca, ineffectiveness, and manufacturer recalls that most recently have even been fatal. Therefore, sleep surgery continues to be an increasingly utilized treatment option for patients with OSA who cannot tolerate or obtain CPAP. However postoperatively, patients typically complain of significant pain, sometimes requiring a significant course of narcotic pain medication, odynophagia, and dysphagia. These side effects often can make patients hesitant to pursue sleep surgery and carry the risk of patients becoming dehydrated and malnourished postoperatively, which can lead to representation to the Emergency Department. Minimal research currently exists on how to improve treating pain, odynophagia, and dysphagia in this patient population. One study by Williams et al. evaluated the use of a one-time dose of intravenous or intramuscular dose of steroids versus placebo after uvulopalatopharyngoplasty but did not find a clinically significant difference between the two groups postoperatively. However, in their study, they mention that likely their intervention was too short, and that further investigation into a longer course of steroid treatment, our current intervention for this study, could potentially show clinically significant improvements. Furthermore, there have been a few randomized controlled trials showing that a course of steroids improve pain and narcotic consumption after tonsillectomy in adults. However, no research has studies the postoperative effects of steroids on other sleep surgeries, such as palatopharyngoplasty, hypoglossal nerve stimulation, genioglossus advancement, or maxillomandibular advancement. Investigators hypothesize that postoperative steroids will be superior to no steroids in terms of pain, dysphagia, and narcotic usage.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years or older
  • Undergoing sleep surgery, specifically palatopharyngoplasty, tonsillectomy with or without adenoidectomy, uvulectomy, hypoglossal nerve stimulation, genioglossal advancement, or maxillomandibular advancement
  • Ability to complete all study questions in English

排除标准

  • Any self-reported allergies to corticosteroids
  • Intra-operative surgical or anesthetic complication
  • Pre-operative steroid use (defined as any steroid use greater than three days duration within 30 days prior to sleep surgery)
  • Inability to perform study due to underlying medical condition
  • Inability to answer postoperative questionnaires due to underlying medical conditions

研究组 & 干预措施

3 doses of intravenous placebo with 3 doses of oral 8mg dexamethasone

Other

Placebo administered intravenously, while the experimental drug is administered orally

干预措施: 8mg dexamethasone (Drug)

3 doses of intravenous placebo with 3 doses of placebo

Placebo Comparator

Placebo administered both intravenously and orally

干预措施: 8mg dexamethasone (Drug)

3 doses of intravenous 8mg dexamethasone with 3 doses of oral 8mg dexamethasone

Experimental

Experimental drug administered both intravenously and orally

干预措施: 8mg dexamethasone (Drug)

3 doses of intravenous 8mg dexamethasone with 3 doses of placebo

Other

Experimental drug administered intravenously, while the placebo is administered orally

干预措施: 8mg dexamethasone (Drug)

结局指标

主要结局

Pain control

时间窗: 2 weeks

As determined by a validated visual analog scale, with scores being scaled from 0 to 10, with 0 being the lowest score (no pain) and 10 being the highest score (most extreme amount of pain)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Abdelwahab

Assistant Professor-Faculty

Medical University of South Carolina

研究点 (2)

Loading locations...

相似试验